Author Archives: Bradley Olson

Rapid advancements in science and technology may be changing healthcare delivery, but the heart of medicine continues to be the relationship between doctor and patient. When David Howell, PhD (’78), a medical writer for peer-reviewed journals in San Francisco, moved back to North Carolina in late 2020, he needed to...

Division of Nephrology and Hypertension Keia Sanderson, MD, MSCR, has received an NIH K23 award, supported by the NIDDK, to identify maternal and neonatal risk factors to help predict childhood kidney disease earlier. Division of Geriatric Medicine John A. Batsis, MD, was awarded a five-year, $3.5-million R01 grant by the National Institute on Aging to...

Division of Rheumatology, Allergy and Immunology Richard F. Loeser, Jr., MD,  received a $2 million NIH grant to study “Oxidative Stress and the Development of Osteoarthritis”

Division of Hematology Shakira Grant, MBBS, received a one-year, $11.5K grant from the National Heart Lung and Blood Institute Programs to Increase Diversity Among Individuals Engaged in Health-Related Research (PRIDE). Callie Berkowitz, MD, was awarded a grant from Foundation for Women and Girls with Blood Disorders. Alice Ma, MD, FACP, and Nigel Key,...

Division of Oncology Jacob Stein, MD, MPH, received a $50K award for UNC Adolescents and Young Adult Cancer Program: Reach and Influence on Cancer Care Delivery. Ashwin Somasundaram, MD, received the $150K Lineberger Developmental Award and the $50K Pancreatic SPORE Career Enhancement Award Grant. Division of Pulmonary Diseases and Critical Care...

Division of Infectious Diseases Arlene Seña, MD, MPH, received $1.9 Million to advance diagnostic product development for syphilis.

Division of Rheumatology, Allergy and Immunology Mildred Kwan, MD, PhD, and team received a Pfizer grant to address health disparities in antimicrobial stewardship. Division of Pulmonary Diseases and Critical Care Medicine Scott Randell, PhD, was awarded a $2 million grant titled, “Validation of the RD-X19 COVID Treatment Device toward Regulatory Approval and Commercialization.”

As we all desperately await a way to treat COVID-19, beyond prevention, the following publication has metrics that are incredible (following February publication, by December 2021 it had been accessed >107K times with a >1700 Altimetric).